Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, IL 61605, USA.
Neoplasia. 2013 Feb;15(2):192-203. doi: 10.1593/neo.121334.
Our previous studies have shown the role of radiation-induced urokinase plasminogen activator (uPA) expression in the progression of meningioma. In the present study, we investigated whether modulation of DNA methylation profiles could regulate uPA expression. Initially, radiation treatment was found to induce hypomethylation in meningioma cells with a decrease in DNA (cytosine-5)-methyltransferase 1 (DNMT1) and methyl-CpG binding domain protein (MBD) expression. However, oxidative damage by H(2)O(2) or pretreatment of irradiated cells with N-acetyl cysteine (NAC) did not show any influence on these proteins, thereby indicating a radiation-specific change in the methylation patterns among meningioma cells. Further, we identified that hypomethylation is coupled to an increase in uPA expression in these cells. Azacytidine treatment induced a dose-dependent surge of uPA expression, whereas pre-treatment with sodium butyrate inhibited radiation-induced uPA expression, which complemented our prior results. Methylation-specific polymerase chain reaction on bisulfite-treated genomic DNA revealed a diminished methylation of uPA promoter in irradiated cells. Transfection with small hairpin RNA (shRNA)-expressing plasmids targeting CpG islands of the uPA promoter showed a marked decline in uPA expression with subsequent decrease in invasion and proliferation of meningioma cells. Further, radiation treatment was found to recruit SP1 transcription factor, which was abrogated by shRNA treatment. Analysis on signaling events demonstrated the activation of MAP kinase kinase (MEK)-extracellular signal-regulated kinase (ERK) in radiation-treated cells, while U0126 (MEK/ERK inhibitor) blocked hypomethylation, recruitment of SP1, and uPA expression. In agreement with our in vitro data, low DNMT1 levels and high uPA were found in intracranial tumors treated with radiation compared to untreated tumors. In conclusion, our data suggest that radiation-mediated hypomethylation triggers uPA expression in meningioma cells.
我们之前的研究表明,辐射诱导的尿激酶纤溶酶原激活物(uPA)表达在脑膜瘤的进展中起作用。在本研究中,我们研究了 DNA 甲基化谱的调节是否可以调节 uPA 表达。最初,发现辐射处理诱导脑膜瘤细胞中低甲基化,导致 DNA(胞嘧啶-5)-甲基转移酶 1(DNMT1)和甲基-CpG 结合域蛋白(MBD)表达减少。然而,H₂O₂的氧化损伤或用 N-乙酰半胱氨酸(NAC)预处理辐照细胞并没有对这些蛋白产生任何影响,这表明脑膜瘤细胞中的甲基化模式发生了辐射特异性变化。此外,我们发现低甲基化与这些细胞中 uPA 表达的增加有关。阿扎胞苷处理诱导 uPA 表达的剂量依赖性增加,而用丁酸钠预处理则抑制辐射诱导的 uPA 表达,这与我们之前的结果相补充。用 bisulfite 处理的基因组 DNA 进行甲基化特异性聚合酶链反应显示,辐照细胞中 uPA 启动子的甲基化程度降低。用靶向 uPA 启动子 CpG 岛的短发夹 RNA(shRNA)表达质粒转染显示 uPA 表达明显下降,随后脑膜瘤细胞的侵袭和增殖减少。此外,发现辐射处理招募 SP1 转录因子,而 shRNA 处理则消除了这种招募。信号事件分析表明,MAP 激酶激酶(MEK)-细胞外信号调节激酶(ERK)在辐射处理的细胞中被激活,而 U0126(MEK/ERK 抑制剂)阻断低甲基化、SP1 募集和 uPA 表达。与我们的体外数据一致,与未治疗的肿瘤相比,接受辐射治疗的颅内肿瘤中 DNMT1 水平较低,uPA 水平较高。总之,我们的数据表明,辐射介导的低甲基化触发脑膜瘤细胞中 uPA 的表达。